Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinsons disease 2014

Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer's brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants 2002

Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptor 1996

Quantitative analysis of the olfactory pathway for drug delivery to the brain 1995

Inhibitor of antagonist binding to the muscarinic receptor is elevated in Alzheimer's brain 1994